International
Urology Cancer Summit 2025
Portsmouth, UK – 4th & 5th, September, 2025
International Urology Cancer Summit 2025
Portsmouth, UK
4th & 5th, September, 2025
This congress is sponsored by pharmaceutical companies.
For a full list of sponsors, check the sponsor page.

The International Urology Cancer Summit is a free and independent educational opportunity open to everyone involved in caring for patients with urologic cancers.
Through an interactive platform with the live streaming and on-demand presentations from globally renowned experts present on site, and follow-up content on a dedicated website, you will be able to keep up with the state-of-the-art management of urologic cancers.
All 2024 live sessions have been recorded and are available here
Make sure you are registered. Kindly note that the webcast event is not CPD/CME accredited.
Chair Members

Giuseppe Luigi Banna
Consultant Medical Oncologist, MD
Honorary Associate Professor, Department of Oncology,
Portsmouth Hospitals University NHS Trust, University of Portsmouth, UK

Ravindran Kanesvaran
Assoc Prof, MD, MRCP (UK), FAMS (Med Oncol)
Deputy Chair and Senior Consultant, Division of Medical Oncology, National Cancer Centre, Singapore.
Faculty 2025
Giuseppe Banna
UK
Ravindran Kanesvaran
Singapore
Neeraj Agarwal
USA
Sumanta Kumar Pal
USA
Alison Tree
UK
Yüksel Ürün
TURKEY
Partha S. Choudhury
India
Pasquale Rescigno
UK
Simon Crabb
UK
Param Mariappan
UK
Amit Bahl
UK
Enrique Grande
Spain
Stefanie Zschäbitz
Germany
Sara Elena Rebuzzi
Italy
John McGrane
UK
Laurence Albiges
France
Petros Grivas
USA
Ben Lamb
UK
María Natalia Gandur Quiroga
Argentina
Akash Maniam
UK
Aruni Ghose
UK
Matteo Santoni
Italy
Scientific Committee
• Giuseppe Luigi Banna • Maria Natalia Gandur Quiroga • Ravindran Kanesvaran • Michele Maffezzoli • Akash Maniam • Pasquale Rescigno • Matteo Santoni • Yüksel Ürün
International Urology Cancer Summit has been approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for 6 category 1 (external) CPD credit(s).- for in- person participants ONLY.